Response to: ‘Should patients starting biologics be screened for COVID-19?’ by Cardenas-de la Garza et al
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-218470
Abstract: Cardenas-de la Garza et al 1 ask a reasonable question that nowadays likely resonates in many rheumatological practices: “Should we screen our patients who start biologics for SARS-CoV-2?” As so often in medicine, the question… read more here.
Keywords: biologics screened; patients starting; response patients; starting biologics ... See more keywords